Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy

Abstract : To conduct a prospective randomized trial to investigate the effect of glucagon-like peptide-1 (GLP-1) analogues on ectopic fat stores.
Type de document :
Article dans une revue
Diabetes, Obesity and Metabolism, Wiley, 2016, 18 (9), pp.882 - 891. 〈10.1111/dom.12680〉
Liste complète des métadonnées

https://hal.archives-ouvertes.fr/hal-01770003
Contributeur : Jean-Charles Martin <>
Soumis le : mercredi 18 avril 2018 - 15:07:07
Dernière modification le : mardi 11 décembre 2018 - 01:24:52

Identifiants

Citation

Jean-Charles Martin, M Dutour, B Abdesselam, M Ancel, B Kober, et al.. Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy. Diabetes, Obesity and Metabolism, Wiley, 2016, 18 (9), pp.882 - 891. 〈10.1111/dom.12680〉. 〈hal-01770003〉

Partager

Métriques

Consultations de la notice

322